Effect of ropinirole on patients with myoclonic dystonia: 2025 update

WorkSafeBC Evidence-Based Practice Group, Martin CW
Record ID 32018015244
English
Authors' objectives: To determine whether there is any evidence on the effectiveness of ropinirole in patients with myoclonic dystonia.
Authors' results and conclusions: 63 published studies were identified through the literature searches. Upon examination of the titles and abstracts of these published studies, there was one study thought to be relevant to ropinirole use in treating myoclonic dystonia. A manual search revealed one additional paper. Therefore, there are two new published studies that are relevant to this systematic review. In this 2025 update, there were two additional low-level, low-quality studies that add to the evidence. However, there were no additional high-quality published studies and the original conclusions remain.
Authors' methods: A comprehensive and systematic literature search was conducted on December 4, 2025. The search was done on commercial medical literature databases where a combination of key words was employed in this search. The search was done by employing combinations of keywords. Only studies between 2020 through 2025 were included. No other limitations were implemented in any of these searches. A manual search was also planned and conducted on the references of the articles that were retrieved in full.
Details
Project Status: Completed
URL for project: https://www.worksafebc.com/en/about-us/research-services/evidence-based-medicine-and-systematic-reviews
Year Published: 2025
URL for published report: https://www.worksafebc.com/en/resources/health-care-providers/guides/effect-of-ropinirole-on-patients-with-myoclonic-dystonia-2025-update?lang=en&origin=s&returnurl=https%3A%2F%2Fwww.worksafebc.com%2Fen%2Fforms-resources%23sort%3DDate%26q%3DEffect%2520of%2520Ropinirole%2520on%2520Patients%2520with%2520Myoclonic%2520Dystonia%253A%25202025%2520Update%26f%3Alanguage-facet%3D%5BEnglish%5D%26tags%3DHealth%2520Care%2520Provider%7C13468b0b3f074f6bade3f57ac3cdfb8e%2CSystematic%2520Review%7Cf78c29d570c14ec3b5a394385905df70&highlight=Effect%20of%20Ropinirole%20on%20Patients%20with%20Myoclonic%20Dystonia:%202025%20Update
English language abstract: An English language summary is available
Publication Type: Mini HTA
Country: Canada
MeSH Terms
  • Dystonia
  • Dystonic Disorders
  • Antiparkinson Agents
  • Dopamine Agonists
Keywords
  • myoclonus dystonia
  • dystonic disorders
  • dystonia
  • ropinirole
Contact
Organisation Name: WorkSafeBC
Contact Address: 6591 Westminster Highway, Richmond, BC, V7C 1C6 Canada. Tel: 604-231-8417; Fax: 604-279-7698
Contact Name: ebpg@worksafebc.com
Contact Email: ebpg@worksafebc.com
Copyright: WorkSafe BC
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.